Incyte Corp. (INCY)
113.08
+0.33
(+0.29%)
USD |
NASDAQ |
Oct 09, 13:04
Incyte 30-Day Average Daily Volume : 1.595M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.595M |
| October 07, 2026 | 1.558M |
| October 06, 2026 | 1.554M |
| October 05, 2026 | 1.499M |
| October 02, 2026 | 1.479M |
| October 01, 2026 | 1.447M |
| September 30, 2026 | 1.421M |
| September 29, 2026 | 1.407M |
| September 28, 2026 | 1.418M |
| September 25, 2026 | 1.396M |
| September 24, 2026 | 1.383M |
| September 23, 2026 | 1.372M |
| September 22, 2026 | 1.357M |
| September 21, 2026 | 1.347M |
| September 18, 2026 | 1.356M |
| September 17, 2026 | 1.312M |
| September 16, 2026 | 1.323M |
| September 15, 2026 | 1.347M |
| September 14, 2026 | 1.342M |
| September 11, 2026 | 1.355M |
| September 10, 2026 | 1.395M |
| September 09, 2026 | 1.444M |
| September 08, 2026 | 1.598M |
| September 04, 2026 | 1.646M |
| September 03, 2026 | 1.651M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.653M |
| September 01, 2026 | 1.609M |
| August 31, 2026 | 1.633M |
| August 28, 2026 | 1.625M |
| August 27, 2026 | 1.659M |
| August 26, 2026 | 1.681M |
| August 25, 2026 | 1.707M |
| August 24, 2026 | 1.711M |
| August 21, 2026 | 1.734M |
| August 20, 2026 | 1.743M |
| August 19, 2026 | 1.748M |
| August 18, 2026 | 1.758M |
| August 17, 2026 | 1.774M |
| August 14, 2026 | 1.748M |
| August 13, 2026 | 1.810M |
| August 12, 2026 | 1.839M |
| August 11, 2026 | 1.865M |
| August 10, 2026 | 1.880M |
| August 07, 2026 | 1.961M |
| August 06, 2026 | 1.971M |
| August 05, 2026 | 1.957M |
| August 04, 2026 | 1.953M |
| August 03, 2026 | 1.957M |
| July 31, 2026 | 2.045M |
| July 30, 2026 | 2.041M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Regeneron Pharmaceuticals, Inc. | 720681.1 |
| Mirum Pharmaceuticals, Inc. | 744641.7 |
| Vertex Pharmaceuticals, Inc. | 1.013M |
| Alnylam Pharmaceuticals, Inc. | 1.503M |
| AbbVie, Inc. | 4.415M |